342 related articles for article (PubMed ID: 27725193)
1. Emerging therapies for neuropathic lysosomal storage disorders.
Kelly JM; Bradbury A; Martin DR; Byrne ME
Prog Neurobiol; 2017 May; 152():166-180. PubMed ID: 27725193
[TBL] [Abstract][Full Text] [Related]
2. Targeting the central nervous system in lysosomal storage diseases: Strategies to deliver therapeutics across the blood-brain barrier.
Critchley BJ; Gaspar HB; Benedetti S
Mol Ther; 2023 Mar; 31(3):657-675. PubMed ID: 36457248
[TBL] [Abstract][Full Text] [Related]
3. New Advanced Strategies for the Treatment of Lysosomal Diseases Affecting the Central Nervous System.
Gigliobianco MR; Di Martino P; Deng S; Casadidio C; Censi R
Curr Pharm Des; 2019; 25(17):1933-1950. PubMed ID: 31566121
[TBL] [Abstract][Full Text] [Related]
4. Enzyme Replacement Therapy: A Review and Its Role in Treating Lysosomal Storage Diseases.
Li M
Pediatr Ann; 2018 May; 47(5):e191-e197. PubMed ID: 29750286
[TBL] [Abstract][Full Text] [Related]
5. Treatment of lysosomal storage diseases: recent patents and future strategies.
Ortolano S; Viéitez I; Navarro C; Spuch C
Recent Pat Endocr Metab Immune Drug Discov; 2014 Jan; 8(1):9-25. PubMed ID: 24433521
[TBL] [Abstract][Full Text] [Related]
6. CNS-directed gene therapy for lysosomal storage diseases.
Sands MS; Haskins ME
Acta Paediatr; 2008 Apr; 97(457):22-7. PubMed ID: 18339183
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for lysosomal storage disorders.
Barranger JM; Novelli EA
Expert Opin Biol Ther; 2001 Sep; 1(5):857-67. PubMed ID: 11728220
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy for lysosomal storage diseases and peroxisomal diseases.
Ohashi T
J Hum Genet; 2019 Feb; 64(2):139-143. PubMed ID: 30498239
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for lysosomal storage diseases (LSDs) in large animal models.
Haskins M
ILAR J; 2009; 50(2):112-21. PubMed ID: 19293456
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic Stem Cell Gene Therapy for Storage Disease: Current and New Indications.
Biffi A
Mol Ther; 2017 May; 25(5):1155-1162. PubMed ID: 28389320
[TBL] [Abstract][Full Text] [Related]
11. Combination Therapies for Lysosomal Storage Diseases: A Complex Answer to a Simple Problem.
Macauley SL
Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1(Suppl 1):639-48. PubMed ID: 27491211
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I.
Penati R; Fumagalli F; Calbi V; Bernardo ME; Aiuti A
J Inherit Metab Dis; 2017 Jul; 40(4):543-554. PubMed ID: 28560469
[TBL] [Abstract][Full Text] [Related]
13. Treatments for lysosomal storage disorders.
Lachmann R
Biochem Soc Trans; 2010 Dec; 38(6):1465-8. PubMed ID: 21118108
[TBL] [Abstract][Full Text] [Related]
14. New strategies for the treatment of lysosomal storage diseases (review).
Parenti G; Pignata C; Vajro P; Salerno M
Int J Mol Med; 2013 Jan; 31(1):11-20. PubMed ID: 23165354
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for lysosomal storage diseases: the lessons and promise of animal models.
Ellinwood NM; Vite CH; Haskins ME
J Gene Med; 2004 May; 6(5):481-506. PubMed ID: 15133760
[TBL] [Abstract][Full Text] [Related]
16. [Current therapeutic strategies in lysosomal disorders].
Kaminsky P; Lidove O
Presse Med; 2014 Nov; 43(11):1174-84. PubMed ID: 24863660
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy approaches for lysosomal storage disease: next-generation treatment.
Byrne BJ; Falk DJ; Clément N; Mah CS
Hum Gene Ther; 2012 Aug; 23(8):808-15. PubMed ID: 22794786
[TBL] [Abstract][Full Text] [Related]
18. Intrauterine enzyme replacement therapies for lysosomal storage disorders: Current developments and promising future prospects.
Herzeg A; Borges B; Lianoglou BR; Gonzalez-Velez J; Canepa E; Munar D; Young SP; Bali D; Gelb MH; Chakraborty P; Kishnani PS; Harmatz P; Cohen JL; MacKenzie TC
Prenat Diagn; 2023 Dec; 43(13):1638-1649. PubMed ID: 37955580
[TBL] [Abstract][Full Text] [Related]
19. Large animal models contribute to the development of therapies for central and peripheral nervous system dysfunction in patients with lysosomal storage diseases.
Gurda BL; Vite CH
Hum Mol Genet; 2019 Oct; 28(R1):R119-R131. PubMed ID: 31384936
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic approaches for lysosomal storage diseases: a patent update.
Urbanelli L; Sagini K; Polidoro M; Brozzi A; Magini A; Emiliani C
Recent Pat CNS Drug Discov; 2013 Aug; 8(2):91-109. PubMed ID: 23713988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
